Agios Pharmaceuticals
AGIO
#5067
Rank
A$2.67 B
Marketcap
A$44.82
Share price
-1.73%
Change (1 day)
-27.48%
Change (1 year)

Earnings for Agios Pharmaceuticals (AGIO)

Earnings in 2026 (TTM): -A$0.68 Billion

According to Agios Pharmaceuticals 's latest financial reports the company's current earnings are A$98.33 Million. In 2025 the company made an earning of -A$0.68 Billion a decrease over its 2024 earnings that were of -A$0.62 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Agios Pharmaceuticals from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.68 Billion0.01%
2025 -A$0.68 Billion10.9%
2024 -A$0.62 Billion8.75%
2023 -A$0.57 Billion0.63%
2022 -A$0.56 Billion2.81%
2021 -A$0.55 Billion10.58%
2020 -A$0.5 Billion-18.41%
2019 -A$0.61 Billion15.72%
2018 -A$0.52 Billion12.99%
2017 -A$0.47 Billion59.61%
2016 -A$0.29 Billion69.32%
2015 -A$0.18 Billion119.28%
2014 -A$77.64 Million39.22%
2013 -A$55.77 Million69.1%
2012 -A$32.98 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$9.90 B-1,604.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$48.18 B-7,418.92%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$11.31 B-1,818.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
Xencor
XNCR
-A$0.24 Billion-64.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
A$1.48 B-325.58%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$0.21 B-132.48%๐Ÿ‡บ๐Ÿ‡ธ USA